Enveric Biosciences's total assets for Q2 2024 were $6.05M, a decrease of -31.62% from the previous quarter. ENVB total liabilities were $645.34K for the fiscal quarter, a -72.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.